A detailed history of Gabelli Funds LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gabelli Funds LLC holds 334,800 shares of BMY stock, worth $19.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
334,800
Previous 366,450 8.64%
Holding current value
$19.3 Million
Previous $15.2 Million 13.85%
% of portfolio
0.14%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$39.66 - $51.75 $1.26 Million - $1.64 Million
-31,650 Reduced 8.64%
334,800 $17.3 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $1.19 Million - $1.57 Million
-29,600 Reduced 7.47%
366,450 $15.2 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $3.25 Million - $3.68 Million
-67,645 Reduced 14.59%
396,050 $21.5 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $58,903 - $70,287
-1,215 Reduced 0.26%
463,695 $23.8 Million
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $1.11 Million - $1.24 Million
-19,150 Reduced 3.96%
464,910 $27 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $416,663 - $462,639
-6,540 Reduced 1.33%
484,060 $31 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $188,916 - $214,273
2,875 Added 0.59%
490,600 $34 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $202,016 - $239,215
-2,950 Reduced 0.6%
487,725 $35.1 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $2,628 - $1.55 Million
-20,223 Reduced 3.96%
490,675 $34.9 Million
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $954,226 - $1.05 Million
-13,140 Reduced 2.51%
510,898 $39.3 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $1.45 Million - $1.74 Million
-23,550 Reduced 4.3%
524,038 $38.3 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $3.74 Million - $4.36 Million
-69,658 Reduced 11.29%
547,588 $34.1 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $1.77 Million - $2.07 Million
-29,916 Reduced 4.62%
617,246 $36.5 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $209,255 - $227,879
-3,380 Reduced 0.52%
647,162 $43.2 Million
Q1 2021

May 14, 2021

BUY
$59.34 - $66.74 $1.85 Million - $2.09 Million
31,242 Added 5.04%
650,542 $41.1 Million
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $4.44 Million - $5.03 Million
-76,950 Reduced 11.05%
619,300 $38.4 Million
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $2.35 Million - $2.61 Million
-41,000 Reduced 5.56%
696,250 $42 Million
Q2 2020

Aug 13, 2020

SELL
$54.82 - $64.09 $23.3 Million - $27.3 Million
-425,310 Reduced 36.58%
737,250 $43.4 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $2.64 Million - $3.83 Million
-56,840 Reduced 4.66%
1,162,560 $64.8 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $28 Million - $36.5 Million
569,400 Added 87.6%
1,219,400 $78.3 Million
Q3 2019

Nov 01, 2019

SELL
$42.77 - $50.71 $1.15 Million - $1.37 Million
-26,987 Reduced 3.99%
650,000 $33 Million
Q2 2019

Aug 02, 2019

SELL
$44.62 - $49.34 $557,750 - $616,750
-12,500 Reduced 1.81%
676,987 $30.7 Million
Q1 2019

May 02, 2019

SELL
$45.12 - $53.8 $1.46 Million - $1.74 Million
-32,300 Reduced 4.48%
689,487 $32.9 Million
Q4 2018

Jan 30, 2019

SELL
$48.76 - $63.23 $146,280 - $189,690
-3,000 Reduced 0.41%
721,787 $37.5 Million
Q3 2018

Nov 02, 2018

BUY
$55.19 - $62.25 $38,633 - $43,575
700 Added 0.1%
724,787 $45 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $1.26 Million - $1.57 Million
-25,000 Reduced 3.34%
724,087 $40.1 Million
Q1 2018

May 09, 2018

BUY
$59.92 - $68.98 $1.66 Million - $1.91 Million
27,700 Added 3.84%
749,087 $47.4 Million
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $6.35 Million - $6.93 Million
-106,000 Reduced 12.81%
721,387 $44.2 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $45.7 Million - $52.7 Million
827,387
827,387 $52.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.